MiR-618 suppresses the proliferation, invasion, and migration of non-small lung cancer via the JAK2/STAT3 axis

Read the full article

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objective The regulatory role of the miR-618/JAK2/STAT3 axis in non-small cell lung cancer (NSCLC) cells was investigated with the objective of identifying a target for the precise treatment of patients with NSCLC. Methods Differentially expressed genes were identified in the GEO database and were analyzed bioinformatically. The tissue and cell levels of miR-618 were assessed using qRT-PCR, while the protein levels of JAK2 and STAT3 were determined through western blotting analysis.The association between miR-618 and JAK2 was scrutinized through bioinformatics analysis and dual-luciferase experiments. To evaluate cell proliferation, migration, and invasion, MTT, wound-healing, and Transwell assays were employed. RESULTS MiR-618 expression decreased in NSCLC, leading to the inhibition of growth, invasiveness, and migratory properties of non-small cell lung cancer. This is achieved by MiR-618 modulating the JAK2/STAT3 signaling pathway. In addition, miR-618 inhibited cell proliferation, migration, and invasion by targeting JAK2/STAT3. Conclusion Our study demonstrates that a novel miR-618/JAK2/STAT3 signaling axis is involved in suppressing malignancy in NSCLC and provides a promising target for NSCLC therapy.

Article activity feed